Selexipag improved pulmonary vascular resistance and other hemodynamic variables among patients with chronic thromboembolic pulmonary hypertension, according to results published in European ...

Fetuses with transposition and abnormalities of the foramen ovale and/or ductus arteriosus detected by ultrasound may develop severe hypoxemia postnatally. Higher than normal oxygen content in the ...

An ongoing multicenter study in Japan will evaluate reductions in pulmonary vascular resistance 8 months after initiating the combination therapy in pulmonary arterial hypertension. An ongoing study ...

IT has been suggested 1,2 that severe pulmonary changes, supposedly irreversible, in patients with mitral stenosis would preclude beneficial results from valvulotomy. Recent publications from this ...

AJMC: Can you explain the etiology and progression of PAH and the importance of early diagnosis? HASSOUN: Pulmonary arterial hypertension (PAH) refers to World Health Organization (WHO) group 1 ...

For patients who have pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), treatment with levosimendan (Simdax; Tenax Therapeutics) can improve both pulmonary ...

Vitamin D receptor (VDR) gene polymorphism was studied to find out whether the variants of this gene are associated with susceptibility or resistance to pulmonary tuberculosis (PTB) and ...

This is a preview. Log in through your library . Abstract Patients with chronic obstructive pulmonary disease are generally subjected to multiple regimens of antimicrobial treatment. The development ...

One hundred and twenty patients with mitral stenosis were studied by combined catheterization. Thirty-five of these patients with pure mitral stenosis are the subject of this study. The diagnosis was ...

The World Health Organization symposium offers a new treatment-oriented classification of pulmonary hypertension based on an improved understanding of its pathophysiology. Regardless of the etiology, ...